Atossa Therapeutics, Inc. (ATOS) vs Cellectar Biosciences, Inc. (CLRB)
Atossa Therapeutics, Inc. and Cellectar Biosciences, Inc. are both Biotechnology companies. Atossa Therapeutics, Inc. and Cellectar Biosciences, Inc. are of similar size ($20.5M and $19.6M). Across the 10 metrics below, Cellectar Biosciences, Inc. leads on 6 and Atossa Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | ATOS | CLRB | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (89.23%) | (125.99%) | (57.72%) |
| Return on assets | (77.91%) | (88.70%) | (49.22%) |
| Return on invested capital | (3,918.83%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack